Holding(s) in Company
Rock Nominees Limited, through Mark H Dixon, has acquired a major holding in SkinBioTherapeutics plc, now holding 12.269% of the company's voting rights, representing 31,750,000 shares. This notification signifies an acquisition of voting rights, with the threshold crossed on November 14, 2025, and the issuer was notified on November 17, 2025. There are no indirect holdings or financial instruments with similar economic effects reported.
Select text to share a quote on X · sign in to keep highlights & notes in your SBTX notes
Non-UK issuer
- Reason for the notification (please mark the appropriate box or boxes with an "X")
| An acquisition or disposal of voting rights | X |
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify) iii :
Details of person subject to the notification obligation iv
| Name | Mark H Dixon |
City and country of registered office (if applicable)
Full name of shareholder(s) (if different from 3.) v
| Name | Rock Nominees Limited |
| City and country of registered office (if applicable) | London, UK |
| 5. Date on which the threshold was crossed or reached vi : | 14 November 2025 |
| 6. Date on which issuer notified (DD/MM/YYYY): | 17/11/2025 |
- Total positions of person(s) subject to the notification obligation
| Resulting situation on the date on which threshold was crossed or reached | 12.269% | 12.269% | 31,750,000 |
| Position of previous notification (if applicable) | n/a | n/a | n/a |
| A: Voting rights attached to shares | |||
| Class/type of shares ISIN code (if possible) | Number of voting rights ix | % of voting rights | |
| Direct (DTR5.1) | Indirect (DTR5.2.1) | Direct (DTR5.1) | Indirect (DTR5.2.1) |
| Ordinary shares GB00BF33H870 | 31,750,000 | 12.269% | |
| SUBTOTAL 8. A | 31,750,000 | 12.269% | |
B 1: Financial Instruments according to DTR5.3.1R (1) (a)
SUBTOTAL 8. B 1
B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)
SUBTOTAL 8.B.2
In case of proxy voting, please identify:
| Name of the proxy holder | N/A |
| The number and % of voting rights held | N/A |
| The date until which the voting rights will be held | N/A |
| 11. Additional information xvi | |
| Place of completion | London |
| Date of completion | 17 November 2025 |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.